These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

293 related articles for article (PubMed ID: 26892847)

  • 1. Discontinuation of antidepressant medication after mindfulness-based cognitive therapy for recurrent depression: randomised controlled non-inferiority trial.
    Huijbers MJ; Spinhoven P; Spijker J; Ruhé HG; van Schaik DJ; van Oppen P; Nolen WA; Ormel J; Kuyken W; van der Wilt GJ; Blom MB; Schene AH; Rogier A; Donders T; Speckens AE
    Br J Psychiatry; 2016 Apr; 208(4):366-73. PubMed ID: 26892847
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Adding mindfulness-based cognitive therapy to maintenance antidepressant medication for prevention of relapse/recurrence in major depressive disorder: Randomised controlled trial.
    Huijbers MJ; Spinhoven P; Spijker J; Ruhé HG; van Schaik DJ; van Oppen P; Nolen WA; Ormel J; Kuyken W; van der Wilt GJ; Blom MB; Schene AH; Donders AR; Speckens AE
    J Affect Disord; 2015 Nov; 187():54-61. PubMed ID: 26318271
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Patients with a preference for medication do equally well in mindfulness-based cognitive therapy for recurrent depression as those preferring mindfulness.
    Huijbers MJ; Spinhoven P; van Schaik DJ; Nolen WA; Speckens AE
    J Affect Disord; 2016 May; 195():32-9. PubMed ID: 26852095
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Preventing relapse in recurrent depression using mindfulness-based cognitive therapy, antidepressant medication or the combination: trial design and protocol of the MOMENT study.
    Huijbers MJ; Spijker J; Donders AR; van Schaik DJ; van Oppen P; Ruhé HG; Blom MB; Nolen WA; Ormel J; van der Wilt GJ; Kuyken W; Spinhoven P; Speckens AE
    BMC Psychiatry; 2012 Aug; 12():125. PubMed ID: 22925198
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effectiveness and cost-effectiveness of mindfulness-based cognitive therapy compared with maintenance antidepressant treatment in the prevention of depressive relapse/recurrence: results of a randomised controlled trial (the PREVENT study).
    Kuyken W; Hayes R; Barrett B; Byng R; Dalgleish T; Kessler D; Lewis G; Watkins E; Morant N; Taylor RS; Byford S
    Health Technol Assess; 2015 Sep; 19(73):1-124. PubMed ID: 26379122
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effectiveness and cost-effectiveness of mindfulness-based cognitive therapy compared with maintenance antidepressant treatment in the prevention of depressive relapse or recurrence (PREVENT): a randomised controlled trial.
    Kuyken W; Hayes R; Barrett B; Byng R; Dalgleish T; Kessler D; Lewis G; Watkins E; Brejcha C; Cardy J; Causley A; Cowderoy S; Evans A; Gradinger F; Kaur S; Lanham P; Morant N; Richards J; Shah P; Sutton H; Vicary R; Weaver A; Wilks J; Williams M; Taylor RS; Byford S
    Lancet; 2015 Jul; 386(9988):63-73. PubMed ID: 25907157
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mindfulness-based cognitive therapy for recurrent depression: A translational research study with 2-year follow-up.
    Meadows GN; Shawyer F; Enticott JC; Graham AL; Judd F; Martin PR; Piterman L; Segal Z
    Aust N Z J Psychiatry; 2014 Aug; 48(8):743-55. PubMed ID: 24595511
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Update to the study protocol for a randomized controlled trial comparing mindfulness-based cognitive therapy with maintenance anti-depressant treatment depressive relapse/recurrence: the PREVENT trial.
    Kuyken W; Byford S; Byng R; Dalgleish T; Lewis G; Taylor R; Watkins ER; Hayes R; Lanham P; Kessler D; Morant N; Evans A
    Trials; 2014 Jun; 15():217. PubMed ID: 24916319
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Discontinuing antidepressant medication after mindfulness-based cognitive therapy: a mixed-methods study exploring predictors and outcomes of different discontinuation trajectories, and its facilitators and barriers.
    Huijbers MJ; Wentink C; Simons E; Spijker J; Speckens A
    BMJ Open; 2020 Nov; 10(11):e039053. PubMed ID: 33177138
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A randomized controlled trial of Mindfulness-Based Cognitive Therapy (MBCT) versus treatment-as-usual (TAU) for chronic, treatment-resistant depression: study protocol.
    Cladder-Micus MB; Vrijsen JN; Becker ES; Donders R; Spijker J; Speckens AE
    BMC Psychiatry; 2015 Nov; 15():275. PubMed ID: 26553106
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Study protocol for a randomized controlled trial comparing mindfulness-based cognitive therapy with maintenance anti-depressant treatment in the prevention of depressive relapse/recurrence: the PREVENT trial.
    Kuyken W; Byford S; Byng R; Dalgleish T; Lewis G; Taylor R; Watkins ER; Hayes R; Lanham P; Kessler D; Morant N; Evans A
    Trials; 2010 Oct; 11():99. PubMed ID: 20961444
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antidepressant monotherapy vs sequential pharmacotherapy and mindfulness-based cognitive therapy, or placebo, for relapse prophylaxis in recurrent depression.
    Segal ZV; Bieling P; Young T; MacQueen G; Cooke R; Martin L; Bloch R; Levitan RD
    Arch Gen Psychiatry; 2010 Dec; 67(12):1256-64. PubMed ID: 21135325
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Discontinuation of antidepressant medication in primary care supported by monitoring plus mindfulness-based cognitive therapy versus monitoring alone: design and protocol of a cluster randomized controlled trial.
    Wentink C; Huijbers MJ; Lucassen P; Kramers C; Akkermans R; Adang E; Spijker J; Speckens AEM
    BMC Fam Pract; 2019 Jul; 20(1):105. PubMed ID: 31349796
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Factors associated with relapse and recurrence of major depressive disorder in patients starting mindfulness-based cognitive therapy.
    de Klerk-Sluis JM; Huijbers MJ; Löcke S; Spijker J; Spinhoven P; Speckens AEM; Ruhe HG
    Depress Anxiety; 2022 Feb; 39(2):113-122. PubMed ID: 34752681
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Recovery from recurrent depression with mindfulness-based cognitive therapy and antidepressants: a qualitative study with illustrative case studies.
    Tickell A; Byng R; Crane C; Gradinger F; Hayes R; Robson J; Cardy J; Weaver A; Morant N; Kuyken W
    BMJ Open; 2020 Feb; 10(2):e033892. PubMed ID: 32075835
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prevention of relapse/recurrence in major depressive disorder with either mindfulness-based cognitive therapy or cognitive therapy.
    Farb N; Anderson A; Ravindran A; Hawley L; Irving J; Mancuso E; Gulamani T; Williams G; Ferguson A; Segal ZV
    J Consult Clin Psychol; 2018 Feb; 86(2):200-204. PubMed ID: 29265831
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cost-Utility Analysis of Mindfulness-Based Cognitive Therapy Versus Antidepressant Pharmacotherapy for Prevention of Depressive Relapse in a Canadian Context: Analyse coût-utilité de la thérapie cognitive basée sur la pleine conscience contre la pharmacothérapie antidépressive pour prévenir la rechute de la dépression en contexte canadien.
    Pahlevan T; Ung C; Segal Z
    Can J Psychiatry; 2020 Aug; 65(8):568-576. PubMed ID: 32031000
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Relapse/Recurrence Prevention in Major Depressive Disorder: 26-Month Follow-Up of Mindfulness-Based Cognitive Therapy Versus an Active Control.
    Shallcross AJ; Willroth EC; Fisher A; Dimidjian S; Gross JJ; Visvanathan PD; Mauss IB
    Behav Ther; 2018 Sep; 49(5):836-849. PubMed ID: 30146148
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prevention of relapse/recurrence in major depression by mindfulness-based cognitive therapy.
    Teasdale JD; Segal ZV; Williams JM; Ridgeway VA; Soulsby JM; Lau MA
    J Consult Clin Psychol; 2000 Aug; 68(4):615-23. PubMed ID: 10965637
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Does mindfulness-based cognitive therapy with tapering support reduce risk of relapse/recurrence in major depressive disorder by enhancing positive affect? A secondary analysis of the PREVENT trial.
    Dunn BD; Warbrick L; Hayes R; Montero-Marin J; Reed N; Dalgleish T; Kuyken W
    J Consult Clin Psychol; 2024 Sep; 92(9):619-629. PubMed ID: 39418459
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.